Literature DB >> 35352170

Disseminated nocardiosis after cladribine treatment for relapsing remitting multiple sclerosis: a case report.

Cristian Deana1, Daniele Bagatto2, Alessandra Battezzi3, Davide Pecori4, Simone Lorenzut5, Francesco Tuniz5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35352170     DOI： 10.1007/s00415-022-11097-9

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   6.682


× No keyword cloud information.
  7 in total

1.  Association of British Neurologists: revised (2015) guidelines for prescribing disease-modifying treatments in multiple sclerosis.

Authors:  Neil Scolding; David Barnes; Sarah Cader; Jeremy Chataway; Abhijit Chaudhuri; Alasdair Coles; Gavin Giovannoni; David Miller; Waqar Rashid; Klaus Schmierer; Abdullah Shehu; Eli Silber; Carolyn Young; John Zajicek
Journal:  Pract Neurol       Date:  2015-06-22

2.  Fulminant Central Nervous System Nocardiosis in a Patient Treated With Alemtuzumab for Relapsing-Remitting Multiple Sclerosis.

Authors:  Horst Penkert; Claire Delbridge; Nina Wantia; Benedikt Wiestler; Thomas Korn
Journal:  JAMA Neurol       Date:  2016-06-01       Impact factor: 18.302

Review 3.  Pharmacovigilance during treatment of multiple sclerosis: early recognition of CNS complications.

Authors:  Martijn T Wijburg; Clemens Warnke; Christopher McGuigan; Igor J Koralnik; Frederik Barkhof; Joep Killestein; Mike P Wattjes
Journal:  J Neurol Neurosurg Psychiatry       Date:  2020-11-23       Impact factor: 10.154

4.  Safety and efficacy of cladribine tablets in patients with relapsing-remitting multiple sclerosis: Results from the randomized extension trial of the CLARITY study.

Authors:  Gavin Giovannoni; Per Soelberg Sorensen; Stuart Cook; Kottil Rammohan; Peter Rieckmann; Giancarlo Comi; Fernando Dangond; Abidemi K Adeniji; Patrick Vermersch
Journal:  Mult Scler       Date:  2017-09-05       Impact factor: 6.312

5.  Pulmonary Nocardia beijingensis infection associated with the use of alemtuzumab in a patient with multiple sclerosis.

Authors:  Marwan Sheikh-Taha; Lourdes C Corman
Journal:  Mult Scler       Date:  2017-02-01       Impact factor: 6.312

6.  Cladribine impedes in vitro migration of mononuclear cells: a possible implication for treating multiple sclerosis.

Authors:  T Kopadze; M Döbert; V I Leussink; T Dehmel; B C Kieseier
Journal:  Eur J Neurol       Date:  2009-03       Impact factor: 6.089

Review 7.  Disease-modifying treatments for multiple sclerosis - a review of approved medications.

Authors:  Ø Torkildsen; K-M Myhr; L Bø
Journal:  Eur J Neurol       Date:  2016-01       Impact factor: 6.089
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.